EpiPen Shortage: Trump administration taking action

HHS Secretary Alex Azar on President Trump's plan to lower U.S. drug prices, the import of drugs from China and the EpiPen shortage.

Alex Azar, Health And Human Services secretary on Monday told FOX Business the administration is taking swift action to address the nationwide EpiPen shortage.

“We are working with the manufacturer to make sure that consumers have ready information about where the product is available,” he told Maria Bartiromo on “Mornings with Maria.”

The Food and Drug Administration said last week that Mylan NV’s EpiPen products are in shortage due to manufacturing delays from Meridian Medical Technologies, a Pfizer company.


More Articles